Cargando…
TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer’s disease via TFEB/TFE3 activation
BACKGROUND: The impairment in the autophagy-lysosomal pathway (ALP) and the activation of NLR family pyrin domain containing 3 (NLRP3) inflammasome represent two molecular events leading to neurodegeneration and neuroinflammation in Alzheimer’s disease (AD), a devastating neurodegenerative disorder...
Autores principales: | Lin, Wenjia, Li, Zhao, Liang, Guangfeng, Zhou, Runjin, Zheng, Xiaoyan, Tao, Rongrong, Huo, Qingwei, Su, Chengfu, Li, Min, Xu, Nenggui, Tang, Chunzhi, Song, Ju-Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896717/ https://www.ncbi.nlm.nih.gov/pubmed/36732771 http://dx.doi.org/10.1186/s12974-023-02698-w |
Ejemplares similares
-
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
por: Di Malta, Chiara, et al.
Publicado: (2023) -
TFE3 regulates whole‐body energy metabolism in cooperation with TFEB
por: Pastore, Nunzia, et al.
Publicado: (2017) -
Translation Inhibitors Activate Autophagy Master Regulators TFEB and TFE3
por: Dang, Thao Thi, et al.
Publicado: (2021) -
CDK4/6 regulate lysosome biogenesis through TFEB/TFE3
por: Yin, Qiuyuan, et al.
Publicado: (2020) -
TFEB and TFE3 control glucose homeostasis by regulating insulin gene expression
por: Pasquier, Adrien, et al.
Publicado: (2023)